We are thrilled to announce that our Unlock the Cure Gala Dinner saw us raise an astounding £800,000 to further our mission of finding a cure for follicular lymphoma.
Plain English Summary of the Publication:
Immunogenicity of COVID-19 vaccines in patients with follicular lymphoma receiving frontline chemo-immunotherapy.
The Follicular Lymphoma Foundation (FLF) is thrilled to participate in the upcoming American Society of Hematology (ASH) Annual Meeting.
This session brings together leading experts and a patient who has experienced CAR-T therapy to provide a comprehensive look at emerging therapies for FL, including CAR-T, bispecific antibodies, BTK inhibitors, and more.
Professor Jessica Okosun, FLF Scientific Advisor, answers your questions on chemotherapy-free options
Global patient survey results reveal key insights into patient perspectives on immunotherapy and information preferences
Our webinars are free, interactive, and designed to empower everyone affected by FL. Register today and stay informed on these important discussions.
We are pleased to announce the publication of our latest update, “Follicular Lymphoma: Mid-year Update on Pathways for Clinical and Translational Investigations.
This inspiring session on Relapsed FL, which took place on September 26th 2024, provided the audience with valuable expert discussion and a patient perspective.
Every 3 minutes, someone in the U.S. is diagnosed with blood cancer. Blood Cancer Awareness Month highlights leukemia, lymphoma, and myeloma.
Anne and Stewart recently completed an incredible 432-mile cycling journey in Scotland, raising over £2000 for the FLF.
View our webinar focused on sharing experiences and improving understanding of clinical trials.
Huge thanks to Tadmarton Heath Golf Club for hosting a charity event that raised over £6,000 for the FLF!
This strategic alliance with LLS and IFLI will further accelerate pioneering research and help cure follicular lymphoma through our Research United to CURE FL program.
The team updates from recent scientific conferences on the latest research in follicular lymphoma, from cutting-edge therapies to genetic insights.
Mark is going on an incredible 540 mile walk across the Pyrenees from the Atlantic to the Mediterranean.
Minimal/measurable residual disease refers to the small number of cancer cells remaining in the body after treatment.
How do we improve immunotherapy treatments to ensure long-lasting effectiveness, fewer side effects, and ensure they are accessible?
Dr Mitchell Smith, FLF CMO, explains Immunotherapy and what it means for people living with follicular lymphoma in terms of treatment.
Dr Mitchell Smith, FLF CMO, reports on the most exciting presentations at ASH 2023 including fundamental scientific discoveries and ongoing clinic trials.
Tali and Ross took on the incredible challenge of the Mongol Rally, a 10,000-mile dare devil adventure in a tiny 1000cc car.
We are thrilled to announce that this remarkable event saw us raise an astounding £500,000 to further our mission of finding a cure for follicular lymphoma.
The FLF will be attending the prestigious 65th American Society of Hematology (ASH) Annual Meeting & Exposition in San Diego this December.
Rosie took on the challenge of a half marathon alongside her husband and brother-in-law to raise funds for the FLF.
The panel addressed the crucial topic of “Accelerating the Impact of the Cancer Mission Five-Fold” moderated by IQVIA Institutes Executive Director.
Ben embarked on an epic 5-day, 550km cycling journey from London to Paris this past September.
Not many people are aware of Follicular Lymphoma, I wasn’t until my much better half Charlotte was diagnosed with the condition last year.
Our partnership with LLS continues with the second cycle of the “LLS-FLF United to CURE FL Awards”. This strategic alliance will further accelerate pioneering research and help cure follicular lymphoma.
Thank you to Kate for her incredible fundraising, including hosting a great pub quiz in June 2023. Kate’s advice to others who might be considering organising a fundraiser would be to “Just go for it!”.
The FLF joins forces with The Leukemia & Lymphoma Society to bring hope to those living with follicular lymphoma. The partnership marks a significant milestone in accelerating leading edge research.
This article presents key insights from the conference, shedding light on exciting developments in the field. The knowledge and insights we gained left us inspired and energised.
At the 17th International Conference on Malignant Lymphoma (17-ICML), the FLF hosted their own symposium: “What Will it Take to Cure FL?”. Read more to find out the key takeaways and highlights from the symposium.
In just the last six months, we have made tangible progress in advancing research, raising awareness, and working closely with patients.
Dr Mitchell Smith on Future Directions in FL Dr Mitchell Smith, CMO at the FLF, shares his insights in what the future holds for follicular
FLF shines a spotlight on Follicular Lymphoma at upcoming 17-ICML We are thrilled to announce that the Follicular Lymphoma Foundation (FLF) will be taking centre
On May 18th, the FLF hosted our very first webinar called “An Overview of Follicular Lymphoma: What You Need to Know.”
Carolyn recently held a Coronation Afternoon Tea at her workplace to raise money for Follicular Lymphoma. FLF is a charity close to her heart due to
We’re thrilled to share a big step forward in our fight against follicular lymphoma. In April of this year, our founder, Nicola Mendelsohn, officially opened the new branch of the Follicular Lymphoma Foundation in Israel.
The Follicular Lymphoma Foundation (FLF) proudly hosted its first international FL Summit, titled “Joining Forces to Cure Follicular Lymphoma,” in Tel Aviv, Israel. The summit,
ASH Annual Meeting 2022 – summary and key take-outs By Dr Zoe Drymoussi During the 9-12th December 2022, the FLF team attended, in person, for
Looking back over the last 25 years for FL – the Rituximab era By Dr Mitchell Smith, Chief Medical Officer A recent re-publication marking 25
The FLF’s Precision Medicine Programme Research Goals Technical abstract: The FLF undertook extensive landscaping and scoping work, identifying a substantial set of unmet needs in
Research in focus: Bi-specific antibodies approval. By Dr. Zoe Drymoussi Over the last few years, a promising new class of treatments for advanced-stage FL has
FLF are attending the ASH 2022 Annual Meeting We are delighted that some of the team are able to attend the 64th ASH Annual Meeting
New funding of $2 million for research to get one step closer to a cure for Follicular Lymphoma. Our mission at the FLF is to
Henry and Esther Shirman, two supporters that have been with the FLF since day one, recently celebrated their 50th wedding anniversary, and they certainly did
The wonderful Snowdown Colliery Welfare Brass Band recently (October 8th) created a fabulous afternoon of music for the local community of Dover, Kent. The band
Kate Rogers joins from her previous role at GSK plc as Global Finance Transformation Lead at GSK. She also continues to serves as Non-Executive Director
Wonderful Ailsa Vivian and her students at the Vivian Theatre School Dorset, who in June, raised £750 from a amazing dance show, featuring her talented
In May, Richard ran 127 miles along the Leeds and Liverpool canal in under 3 days to raise funds for the FLF and show support
Interesting summary of the impact and effectiveness of antibody responses to SARS- CoV-2 vaccines in patients with hematologic malignancies. A project from Michael J. Garil
For many people living with Follicular Lymphoma, periodic blood tests become a regular feature. There are several reasons you might need blood tests when affected
At the American Society for Hematology (ASH) Annual Meeting in December 2021, the most up-to-date research was shared on Follicular Lymphoma (FL), as well as
Any potential treatments for Follicular Lymphoma (and other forms of Non-Hodgkin lymphoma) must undergo extensive testing. They must be fully researched to confirm that they
On Sunday 3rd October 2021, I ran every single step of the London Marathon for Follicular Lymphoma Foundation. Words honestly cannot express the feeling of
The FLF places the patient at the heart of our organisation. This survey collated the unmet needs and prioritised our research goals.
Dr Mitchell Smith brings to the FLF over three decades of experience focused on blood cancers. The Follicular Lymphoma Foundation (FLF) has today announced the
